SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Rehab program shows promise for scleroderma Patients' daily life
Symptom relief CompletedThis study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The pr…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 23, 2026 11:56 UTC
-
Viagra for fingers? drug tested for scleroderma ulcers
Symptom relief CompletedThis study tested whether sildenafil (the drug in Viagra) can speed up healing of painful finger ulcers in people with scleroderma. 84 participants received either sildenafil or a placebo for 90 days. The main goal was to see how long it took for the ulcers to heal.
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE3 • Sponsor: University Hospital, Lille • Aim: Symptom relief
Last updated Jun 12, 2026 12:09 UTC
-
Tiny particles may hold clues to autoimmune diseases
Knowledge-focused CompletedThis study looked at tiny particles called microparticles in the blood and urine of people with lupus or scleroderma. Researchers wanted to see if these particles could help explain how these diseases work and possibly lead to better diagnosis or treatment. Over 200 adults partic…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 23, 2026 19:34 UTC
-
Could white blood cells drive skin scarring in scleroderma?
Knowledge-focused CompletedThis completed study examined whether eosinophils, a type of white blood cell, contribute to fibrosis (scarring) in systemic sclerosis, an autoimmune disease. Researchers compared blood samples from 40 patients with systemic sclerosis and 30 healthy volunteers, with optional skin…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:56 UTC